190 related articles for article (PubMed ID: 18059157)
21. CARF Is a vital dual regulator of cellular senescence and apoptosis.
Hasan K; Cheung C; Kaul Z; Shah N; Sakaushi S; Sugimoto K; Oka S; Kaul SC; Wadhwa R
J Biol Chem; 2009 Jan; 284(3):1664-72. PubMed ID: 19001376
[TBL] [Abstract][Full Text] [Related]
22. p53-mediated regulation of mitochondrial dynamics plays a pivotal role in the senescence of various normal cells as well as cancer cells.
Kim YY; Um JH; Shin DJ; Jeong DJ; Hong YB; Yun J
FASEB J; 2021 Feb; 35(2):e21319. PubMed ID: 33433933
[TBL] [Abstract][Full Text] [Related]
23. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
[TBL] [Abstract][Full Text] [Related]
24. DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence.
Qian Y; Zhang J; Yan B; Chen X
J Biol Chem; 2008 Feb; 283(5):2896-905. PubMed ID: 18025081
[TBL] [Abstract][Full Text] [Related]
25. The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence.
Tonnessen-Murray CA; Lozano G; Jackson JG
Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27881444
[TBL] [Abstract][Full Text] [Related]
26. Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.
Wang L; Guo X; Wang J; Jiang C; Bosland MC; Lü J; Deng Y
Cancer Prev Res (Phila); 2016 Jan; 9(1):35-42. PubMed ID: 26511486
[TBL] [Abstract][Full Text] [Related]
27. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
28. Human colorectal cancer derived-MSCs promote tumor cells escape from senescence via P53/P21 pathway.
Li G; Zhang R; Zhang X; Shao S; Hu F; Feng Y
Clin Transl Oncol; 2020 Apr; 22(4):503-511. PubMed ID: 31218648
[TBL] [Abstract][Full Text] [Related]
29. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
30. Small Molecule Inhibition of MDM2-p53 Interaction Augments Radiation Response in Human Tumors.
Werner LR; Huang S; Francis DM; Armstrong EA; Ma F; Li C; Iyer G; Canon J; Harari PM
Mol Cancer Ther; 2015 Sep; 14(9):1994-2003. PubMed ID: 26162687
[TBL] [Abstract][Full Text] [Related]
31. Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells.
Nguyen KH; Hachem P; Khor LY; Salem N; Hunt KK; Calkins PR; Pollack A
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):238-46. PubMed ID: 15993550
[TBL] [Abstract][Full Text] [Related]
32. mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53.
Jung SH; Hwang HJ; Kang D; Park HA; Lee HC; Jeong D; Lee K; Park HJ; Ko YG; Lee JS
Oncogene; 2019 Mar; 38(10):1639-1650. PubMed ID: 30337688
[TBL] [Abstract][Full Text] [Related]
33. Pharmacologic p53 activation blocks cell cycle progression but fails to induce senescence in epithelial cancer cells.
Huang B; Deo D; Xia M; Vassilev LT
Mol Cancer Res; 2009 Sep; 7(9):1497-509. PubMed ID: 19737973
[TBL] [Abstract][Full Text] [Related]
34. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP
Nature; 2005 Aug; 436(7051):725-30. PubMed ID: 16079851
[TBL] [Abstract][Full Text] [Related]
35. Senescence Induction by Combined Ionizing Radiation and DNA Damage Response Inhibitors in Head and Neck Squamous Cell Carcinoma Cells.
Dobler C; Jost T; Hecht M; Fietkau R; Distel L
Cells; 2020 Sep; 9(9):. PubMed ID: 32883016
[TBL] [Abstract][Full Text] [Related]
36. The E2F1/Rb and p53/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy.
Udayakumar T; Shareef MM; Diaz DA; Ahmed MM; Pollack A
Semin Radiat Oncol; 2010 Oct; 20(4):258-66. PubMed ID: 20832018
[TBL] [Abstract][Full Text] [Related]
37. Role of polyamines in p53-dependent apoptosis of intestinal epithelial cells.
Bhattacharya S; Ray RM; Johnson LR
Cell Signal; 2009 Apr; 21(4):509-22. PubMed ID: 19136059
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
39. Differential Radiation Sensitivity in p53 Wild-Type and p53-Deficient Tumor Cells Associated with Senescence but not Apoptosis or (Nonprotective) Autophagy.
Xu J; Patel NH; Saleh T; Cudjoe EK; Alotaibi M; Wu Y; Lima S; Hawkridge AM; Gewirtz DA
Radiat Res; 2018 Nov; 190(5):538-557. PubMed ID: 30132722
[TBL] [Abstract][Full Text] [Related]
40. Antagonizing CD105 enhances radiation sensitivity in prostate cancer.
Madhav A; Andres A; Duong F; Mishra R; Haldar S; Liu Z; Angara B; Gottlieb R; Zumsteg ZS; Bhowmick NA
Oncogene; 2018 Aug; 37(32):4385-4397. PubMed ID: 29717261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
